Telehealth stock Hims & Hers ( HIMS) spiked more than 24% in trading Thursday, days after its Super Bowl ad promoting cheaper ...

We recently published a list of 10 Firms Post Double-Digit Gains on Thursday. In this article, we are going to take a look at ...

Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.

The Hims brand has primed people to view both their everyday health and the natural-aging processes as problems that can be ...

Hims & Hers Health (NYSE: HIMS) is surging today. The stock is up 19%, and this is part of a broader 482.5% rally in the past year that has carried this telehealth company to nosebleed levels. Here’s ...

Hims and Hers has been slammed for its Super Bowl commercial that admonished Americans for being obese and shamed the healthcare industry - then promoted its own weight loss drugs. The 60 ...

Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug ...

Hims & Hers sells compounded semaglutide, a version of the active ingredient in Novo Nordisk’s Wegovy and Ozempic drugs. (Hims & Hers Health) Telehealth provider Hims & Hers Health is defending ...

Telehealth company Hims & Hers is running its first Super Bowl ad and it appears to be poised to become one of the most talked about ads in recent memory. The 60 second spot is provocative and ...

Hims & Hers makes its Super Bowl commercial debut in 2025 with a spot for the telehealth company's weight loss medications. Set to the "This Is America" by Childish Gambino (Donald Glover), the ...

San Francisco-headquartered telehealth company Hims & Hers is at the heart of one of the biggest controversies during the Super Bowl. Hims & Hers, which has its headquarters in the Marina ...